View on Pubmed.gov 34483091 | View on doi.org 10.4244/EIJ-D-2...
Transcatheter edge-to-edge mitral valve repair in patients with mitral annulus calcification.
- Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
- Department of Medicine, Universitat Autónoma de Barcelona, Barcelona, Spain.
- Heart Area, Hospital Universitario Central de Asturias, Oviedo, Spain.
- Hospital Clinic de Barcelona, Institut Clinic Cardiovascular, Barcelona, Spain.
- Cardiovascular Institute, Hospital Clinico San Carlos, IdISSC, Madrid, Spain.
- Interventional Cardiology Unit, Hospital Álvaro Cunqueiro, Vigo, Spain.
- Hospital Clínico Universitario Virgen de la Victoria, CIBERCV, Málaga, Spain.
- Department of Cardiology, University Hospital of León, León, Spain.
Abstract
BACKGROUND
MAC is commonly found in patients affected with MR, and it is associated with high morbidity, mortality and worse cardiac surgical outcomes. Transcatheter edge-to-edge repair could be an alternative treatment, although there is little evidence in this population.
AIMS
The aim of this study was to analyse the safety, efficacy and durability of MitraClip implantation in patients affected with mitral regurgitation (MR) and mitral annulus calcification (MAC).
METHODS
We analysed the outcomes of 61 suitable patients affected with severe MR and moderate or severe MAC (the "MAC" group) and 791 patients with no or mild MAC (the "NoMAC" group) treated with the MitraClip device.
RESULTS
Procedural success was similar (91.8% vs 95.1%, p=0.268, in MAC and NoMAC, respectively), with a very low rate of complications. At one-year follow-up, 90.6% of MAC and 79.5% of NoMAC patients had MR grade ≤2 (p=0.129), 80% in both groups remained in NYHA Functional Class ≤II, and a significant reduction in cardiac readmissions was observed (65% vs 78% in MAC vs NoMAC, p=0.145). One-year mortality tended to be higher in MAC patients (19.7% vs 11.3%, p=0.050), with no difference in cardiovascular mortality (15.3% vs 9.2%, p=0.129).
CONCLUSIONS
MitraClip use in selected patients with moderate or severe MAC is safe, feasible and achieves good clinical and echocardiographic results at one-year follow-up.
References
JACC Cardiovasc Interv. 2020 Aug 10;13(15):1733-1748
Eur J Cardiothorac Surg. 2017 Sep 1;52(3):440-444
JACC Cardiovasc Interv. 2017 May 8;10(9):931-939
Circulation. 2014 Sep 9;130(11 Suppl 1):S19-24
Cited by 17 citations (total)
Journal Article Review
Mitral Annular Calcification: Understanding the Disease and Treatment Options.
Electronic publication date July 24, 2025
Marina Urena [...] Mayra Guerrero et al.
Mitral annular calcification (MAC) is a degenerative process that causes calcium deposits along the mitral annulus. The pathophysiological mechanisms contributing...
Journal Article
Feasibility and Outcomes of Mitral Transcatheter Edge-To-Edge Repair in Patients With Variable Degrees of Mitral Annular Calcification.
Electronic publication date October 4, 2023
Taha Hatab [...] Sachin S Goel et al.
Background The clinical significance of mitral annular calcification (MAC) in patients undergoing mitral transcatheter edge-to-edge repair is not well understood....
Conflict of interest statement
MeSH
- •
- •
Specialties
- •
- •
- •
- •